Comparison

NMN vs NR: which NAD+ precursor is better?

NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are the two most popular NAD+ precursors. Both raise blood NAD+ levels. The differences are in the evidence base, cost, bioavailability, and regulatory status. We compare them side by side.

Side-by-side comparison

FeatureNMNNR
Full nameNicotinamide mononucleotideNicotinamide riboside
Evidence gradeB (human RCTs, biomarker outcomes)B (human RCTs, biomarker outcomes)
Steps to NAD+1 step (NMN to NAD+)2 steps (NR to NMN to NAD+)
Human trials10+ published RCTs15+ published RCTs
Trial dose range250 to 1,250 mg/day100 to 1,000 mg/day
Typical product dose500 mg300 mg
Typical price/month$25 to $80$30 to $90
FDA status (US)Not GRAS (marketed as supplement)GRAS affirmed (2022)
EU statusNovel food (pending)Authorized (novel food approved 2019)
Products in our databaseSee NMN productsSee NR products

What is NMN?

NMN is a direct precursor to NAD+. It is one biochemical step away from NAD+ in the salvage pathway. Oral NMN has been shown to raise blood NAD+ levels in multiple human trials. The most common commercial dose is 500 mg per serving. NMN is not GRAS in the US and is pending novel food authorization in the EU, though it is widely sold as a dietary supplement.

Read the full review: NMN ingredient page.

What is NR?

NR (nicotinamide riboside) is a form of vitamin B3. It converts to NMN and then to NAD+ in the cell. NR was granted GRAS status by the FDA in 2022 and was authorized as a novel food in the EU in 2019. NR has more published human trials than NMN, including trials on cardiovascular function, insulin sensitivity, and kidney function.

Read the full review: NR ingredient page.

Key differences

Evidence

Both have evidence grade B. NR has more published human trials (15+ vs 10+), but NMN trials have shown clear NAD+ elevation at lower doses. The quality of evidence is similar. Neither has long-term hard-endpoint data (mortality, disease prevention).

Bioavailability

NMN was long thought to be too large a molecule to cross cell membranes directly, but the discovery of the Slc12a8 transporter challenged this. NR is smaller and converts to NMN inside the cell. In practice, both raise blood NAD+ levels in human trials. The bioavailability debate is not settled.

Cost

NMN is typically cheaper per milligram. NR products tend to be more expensive. However, NR doses are often lower (300 mg vs 500 mg), so the monthly cost difference is smaller than it appears.

Regulatory status

NR has a clearer regulatory path. It is GRAS in the US and authorized as a novel food in the EU. NMN is in regulatory limbo in the EU (novel food pending) and is not GRAS in the US. This affects availability and marketing claims.

Which should you choose?

If regulatory status matters to you (EU residents, for example), NR is the safer choice. If you want the molecule closest to NAD+ in the pathway, NMN is one step away. Both work. Neither is proven to extend lifespan in humans.

Compare specific products: comparison tool. Browse all NMN products and NR products in our database.

Frequently asked questions

Is NMN better than NR?

Neither is clearly better. Both raise blood NAD+ levels in human trials. NMN is one step closer to NAD+ in the biosynthetic pathway. NR has more published human trials and clearer regulatory status. The choice depends on your priorities.

Can I take NMN and NR together?

There is no strong evidence that taking both is better than taking either alone. Both convert to NAD+ through the same pathway. Consult a clinician before combining supplements.

Is NMN legal?

NMN is sold as a dietary supplement in the US. In the EU, it is pending novel food authorization. NR is GRAS in the US and authorized in the EU. Check your local regulations before purchasing.

What is the recommended dose for NMN vs NR?

NMN trials use 250 to 1,250 mg/day. NR trials use 100 to 1,000 mg/day. The most common commercial doses are 500 mg NMN and 300 mg NR per serving. Always consult a clinician.

Related pages